Analysis Generic Engineering Construction and Projects Limited (GENCON)
6/5/2024
Analysis of Generic Engineering Construction and Projects Limited (GENCON)
Generic Engineering Construction and Projects Limited (GENCON) is showing some interesting trends based on the provided data:1. **Price Movement**: The stock price has been fluctuating in the recent days, with the price closing at 35.50 on the most recent trading day. There seems to be some downward pressure as the price closed lower than the opening price on that day.
2. **Technical Indicators**:
- **RSI Indicator**: The Relative Strength Index (RSI) is currently at 27.35, indicating that the stock may be oversold. This could potentially signal a buying opportunity for investors.
- **MACD Indicator**: The Moving Average Convergence Divergence (MACD) is negative, with the MACD line below the signal line. This suggests a bearish trend in the short term.
3. **Moving Averages**:
- The Simple Moving Average (SMA) is at 39.82, the Exponential Moving Average (EMA) is at 40.14, and the Weighted Moving Average (WMA) is at 39.63. These moving averages can be used to identify potential support and resistance levels.
4. **Overall Sentiment**:
- The RSI and MACD indicators suggest a bearish sentiment in the short term. However, the oversold RSI could indicate a potential reversal in the near future.
- Investors should closely monitor the price movements and key support levels to make informed decisions.
Please note that this analysis is based on the provided data and should be supplemented with additional research before making any investment decisions.
Earnings
The company's results for the most recent quarter, ending on April 30, 2025, have not been provided at this time. The previous quarter's results, ending on February 27, 2025, were handled by the Transfer Agent. The quarter before that, ending on January 31, 2025, had results released after hours. The results for the quarter ending on October 31, 2024, were not provided at the time. However, for the quarter ending on August 1, 2024, the company had an EPS estimate of 1.32.Main Statystic ðŸ§
The data provided includes financials, stock statistics, valuation metrics, stock price summary, and dividends and splits information for a specific company.In terms of financials, the company has strong operating cash flow and levered free cash flow, with a positive current ratio. The profit margin and operating margin are also healthy, indicating efficient operations. The company's fiscal year ends in September 2023, and it has shown a positive return on assets and return on equity.
Looking at stock statistics, the company has a low short ratio and a significant percentage of shares held by institutions. The stock price has fluctuated between a fifty-two-week low and high, with a positive change over the period.
Valuation metrics show a relatively high PEG ratio and price-to-book ratio. The company's market capitalization and enterprise value are substantial, with moderate price-to-sales and enterprise-to-EBITDA ratios.
The stock price summary includes beta, moving averages, and the range of prices over the past year. Dividends and splits information shows the company's dividend history, payout ratio, and dividend yield metrics.
Income statement 💸
These are the revenue figures. Here are the conclusions:1. The company's sales revenue has been increasing steadily over the years, from $274.5 billion in 2020 to $383.3 billion in 2023.
2. Despite the increase in sales, the cost of goods sold has also been rising, indicating a potential need for cost management.
3. The gross profit margin has remained relatively stable over the years, suggesting efficient cost control measures.
4. Operating income has shown a positive trend, reaching $114.3 billion in 2023 from $66.3 billion in 2020.
5. Net income has also been increasing consistently, reaching $97 billion in 2023 from $57.4 billion in 2020.
6. Earnings per share (EPS) have shown a slight fluctuation but have generally been on an upward trajectory.
7. The company has been able to maintain a healthy EBITDA margin, indicating strong operational performance.
8. Overall, the financial performance of the company in terms of revenue and profitability has been positive and improving over the years.
Balance Sheet
These are balance sheets. Here are the conclusions:1. The total assets have been increasing over the years, reaching $365,725,000,000 in 2018.
2. Current assets include cash, inventory, and receivables, with cash and cash equivalents showing fluctuations.
3. Non-current assets consist mainly of investments and advances, which have been increasing steadily.
4. Total liabilities have also been increasing, but at a slower pace compared to assets.
5. Shareholders' equity has shown variations but has generally been positive, indicating a healthy financial position.
6. The company has been utilizing short-term debt and accounts payable for its operations.
7. Accumulated depreciation has been significant, affecting the value of non-current assets.
8. Provision for risks and charges has been a consistent part of non-current liabilities.
9. Common stock and retained earnings are significant components of shareholders' equity.
10. The company has been investing in machinery, furniture, and equipment as part of its non-current assets.
Cash Flow 💶
This is a cash flow statement. Here are some conclusions we can draw from the data:1. The company's free cash flow has been fluctuating over the years, with the highest value in 2022 and the lowest in 2020.
2. Operating cash flow has generally been increasing year over year, indicating improved operational efficiency.
3. The company has been consistently paying interest and income taxes, with varying amounts each year.
4. Financing activities show significant fluctuations, especially in common stock repurchases and long-term debt issuances.
5. Investing activities also vary, with notable amounts spent on the sale and purchase of investments.
6. The end cash position has been fluctuating, but generally, the company has maintained a healthy cash reserve.
7. Stock-based compensation has been a significant factor in the company's financial activities.
8. The company has been paying dividends consistently, with varying amounts each year.
9. The company has engaged in acquisitions and divestitures, impacting the investing cash flow.
10. Overall, the company's financial performance seems stable, with some fluctuations in key financial indicators.
Earnings estimate
Based on the analysts' estimates for future quarterly and annual earnings per share (EPS):1. For the current quarter ending on June 30, 2024, the average EPS estimate is $1.23, with a low estimate of $1.18 and a high estimate of $1.26. This shows an improvement compared to the EPS of $1.17 from the same quarter a year ago.
2. For the next quarter ending on September 30, 2024, the average EPS estimate is $1.42, with a low estimate of $1.33 and a high estimate of $1.51. This also indicates growth from the EPS of $1.35 in the same quarter last year.
3. Looking at the estimates for the current fiscal year ending on September 30, 2024, the average EPS estimate is $6.10, ranging from $5.95 to $6.41. This reflects an increase from the EPS of $5.67 for the previous fiscal year.
4. For the next fiscal year ending on September 30, 2025, the average EPS estimate is $6.69, with a low estimate of $5.92 and a high estimate of $7.31. This suggests a growth trajectory from the EPS of $6.10 in the current fiscal year.
Overall, the analysts' estimates point towards a positive outlook for the company's earnings per share, showing a trend of expected growth in both the short term and the long term.
Revenue estimate
Based on the analysts' estimates for the future quarterly and annual sales of the company, we can draw the following conclusions:1. For the current quarter ending on June 30, 2024, the average sales estimate is $77,545,400,000, with a sales growth of 2% compared to the same quarter last year. The number of analysts providing estimates is 25.
2. For the next quarter ending on September 30, 2024, the average sales estimate is $85,501,800,000, with a sales growth of 3% compared to the same quarter last year. The number of analysts providing estimates is 25.
3. For the current fiscal year ending on September 30, 2024, the average sales estimate is $357,772,000,000, with a sales growth of 1% compared to the previous fiscal year. The number of analysts providing estimates is 38.
4. For the next fiscal year ending on September 30, 2025, the average sales estimate is $380,772,000,000, with a sales growth of 6% compared to the current fiscal year. The number of analysts providing estimates is 38.
Overall, the analysts are generally optimistic about the company's future sales performance, with moderate growth expected in both the quarterly and annual sales figures.
Growth estimates
Based on the consensus estimates provided:- The current quarter growth rate is 5.1%
- The next quarter growth rate is estimated to be 5.2%
- The current year growth rate is 7.6%
- The next year growth rate is expected to be 9.7%
- The past 5 years compound annual growth rate (CAGR) is 20.1%
- The next 5 years compound annual growth rate (CAGR) is projected to be 9.7%
From these estimates, we can see that the company is expected to experience a significant increase in growth compared to the past 5 years, with a particularly strong growth rate projected for the next year. The quarterly growth rates are relatively stable, indicating consistent performance in the short term.
Price target
The analysts' forecast for the future price of the security is as follows:- Low: $164
- High: $275
- Median: $201.43
- Average: $204.58
- Current price: $192.25
- Currency: USD
Based on these forecasts, it appears that the analysts are generally optimistic about the future price of the security, with a median forecast above the current price. However, there is a wide range of estimates, from a low of $164 to a high of $275, indicating some uncertainty in the market.
MACD of GENCON
This is not investment advice. Remember to verify the information provided here.
Get access to the full analysis
- Over 35 000 indexes
- CFD, Forex, Crypto and Stocks Exchange
- Over 150 Indicators
- Pattern and candle analysis
- Support and resistance levels
- Fundamental, technical and sentimental analysis
- Power from AI
